Influence of p53 and bcl-2 on chemosensitivity in benign and malignant prostatic cell lines

Urologic Oncology: Seminars and Original Investigations

Volumn 23, Issue 2, 2005, Pages 123-129

  Serafin, Antonio M ^a   Bohm, Lothar ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Apoptosis; bax bcl 2; p53; Prostate cancer

Indexed keywords

ESTRAMUSTINE; ESTRAMUSTINE PHOSPHATE; ETOPOSIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; VINBLASTINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CELL STRUCTURE; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; DRUG EFFECT; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 18144385825     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2004.11.007     Document Type: Article

References (54)

1. D.P. Petrylak Chemotherapy for advanced hormone refractory prostate cancer Urology 54 1999 30 35
2. Y.A. Hannun Apoptosis and the dilemma of cancer chemotherapy Blood 89 1997 1845 1853
3. G. McGill, D.E. Fisher Apoptosis in tumorigenesis and cancer therapy Frontiers Biosci 2 1997 353 379
4. J.C. Reed, T. Miyashita, S. Takayama BCL-2 family proteins regulators of cell death involved in the pathogenesis of cancer and resistance to therapy J Cell Biochem 60 1996 23 32
5. S. Kamesaki, H. Kamesaki, T.J. Jorgensen Bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase-II-induced DNA strand breaks and their repair Cancer Res 53 1993 4251 4256
6. T. Miyashita, J.C. Reed Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line Blood 81 1993 151 157
7. S.W. Lowe, H.E. Ruley, T. Jacks, D.E. Housman p53-dependent apoptosis modulates the cytotoxicity of anticancer agents Cell 74 1993 957 967
8. A.J. Merritt, C.S. Potten, C.J. Kemp The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice Cancer Res 54 1994 614 617
9. M. Fritsche, C. Haessler, G. Brandner Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents Oncogene 8 1993 307 318
10. Q. Zhan, I. Bae, M.B. Kastan The p53-dependent γ-ray response of GADD45 Cancer Res 54 1994 2755 2760
11. W. El-Deiry, J.W. Harper, P.M. O'Connor WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis Cancer Res 54 1994 1169 1174
12. P. May, E. May Twenty years of p53 research structural and functional aspects of the p53 protein Oncogene 18 1999 7621 7636
13. D. Malkin p53 and the Li-Fraumeni syndrome Biochim Biophys Acta 1198 1994 197 213
14. M.E. McCurrach, T.M. Connor, C.M. Knudson bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis Proc Natl Acad Sci 94 1997 2345 2349
15. S.W. Lowe, S. Bodis, A. McClatchey p53 status and the efficacy of cancer therapy in vivo Science 266 1994 807 810
16. R.B. Lock, L. Stribinskiene Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival Cancer Res 56 1996 4006 4012
17. N. Kyprianou, E.D. King, D. Bradbury Bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells Int J Cancer 70 1997 341 348
18. T. Waldman, Y. Zhang, L. Dillehay Cell cycle arrest versus cell death in cancer therapy Nature Med 3 1997 1034 1036
19. J.M. Brown, B.G. Wouters Apoptosis, p53, and tumor cell sensitivity to anticancer agents Cancer Res 59 1999 1391 1399
20. D.G. Tang, A.T. Porter Target to apoptosis a hopeful weapon for prostate cancer Prostate 32 1997 284 293
21. H.J. Muenchen, P.J. Poncza, K.J. Pienta Different Docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3 Urology 57 2001 366 370
22. S.J. Korsmeyer, J.R. Shutter, D.J. Veis Bcl-2/Bax a rheostat that regulates an anti-oxidant pathway and cell death Semin Cancer Biol 4 1993 327 332
23. E. Yang, J. Zha, J. Jockei Bad, a heterodimeric partner for Bcl-XL and Bcl-2 displaces Bax and promotes death Cell 80 1995 285 291
24. T.C. Fisher, A.E. Milner, C.D. Gregory Bcl-2 modulation of apoptosis induced by anticancer drugs resistance to thymidylate stress is independent of classical resistance pathways Cancer Res 53 1993 3321 3326
25. J.C. Reed Bcl-2 and the regulation of programmed cell death J Cell Biol 124 1994 1 6
26. S. Takayama, T. Sato, S. Krajewski Cloning and functional analysis of BAG-1 a novel Bcl-2-binding protein with anti-cell death activity Cell 80 1995 279 284
27. J.C. Reed Bcl-2 prevention of apoptosis as a mechanism of drug resistance Hematol Oncol Clin North Am 9 1995 451 474
28. A. Thomas, S. El Rouby, J.C. Reed Drug-induced apoptosis in B-cell chronic lymphocytic leukemia relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance Oncogene 12 1996 1055 1062
29. S.W. Hayward, R. Dahiya, G.R. Cunha Establishment and characterization of an immortalised but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol 31A 1995 14 24
30. R.K. Bright, C.D. Vocke, M.R. Emmert-Buck Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens Cancer Res 57 1997 995 1002
31. J.S. Horoszewicz, S.S. Leong, E. Kawinski LNCaP model of human prostatic carcinoma Cancer Res 43 1983 1809 1818
32. C.M. Chresta, J.R.W. Masters, J.A. Hickman Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high bax bcl-2 ratio Cancer Res 56 1996 1834 1841
33. J.M. Akudugu, L. Bohm Micronuclei and apoptosis in glioma and neuroblastoma cell lines and role of other lesions in the reconstruction of cellular radiosensitivity Radiat Environ Biophys 40 2001 295 300
34. A.M. Serafin, J.M. Akudugu, L. Bohm Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status Urol Res 30 2002 289 294
35. N. Mirkovic, R.E. Meyn, N.R. Hunter Radiation-induced apoptosis in a murine lymphoma in vivo Radiother Oncol 33 1994 11 16
36. M.M. Weil, C.I. Amos, K.A. Mason Genetic basis of strain variation in levels of radiation-induced apoptosis of thymocytes Radiat Res 146 1996 646 651
37. W.H. Wilson, J. Teruya-Feldstein, T. Fest Relationship of p53, bcl-2 and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas Blood 89 1997 601 609
38. M.B. Kastan, O. Onyekwere, D. Sidransky Participation of p53 protein in the cellular response to DNA damage Cancer Res 51 1991 6304 6311
39. A.F. Wahl, K.L. Donaldson, C. Fairchild Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis Nature Med 2 1996 72 79
40. D.S. Hawkins, G.W. Demers, D.A. Galloway Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents Cancer Res 56 1996 892 898
41. 2/M block abrogation drastically enhances the cytotoxicity of Daunorubicin, Melphalan and Cisplatin in p53 mutant human tumour cells Radiat Res 154 2000 640 649
42. 2 block abrogation Urol Res 29 2001 221 227
43. H. Mueller, U. Eppenberger The dual role of mutant p53 protein in chemosensitivity of human cancers Anticancer Res 16 1996 3845 3848
44. A.J. Klingelhutz, S.A. Foster, J.K. McDougall Telomerase activation by the E6 gene product of human papillomavirus type 16 Nature 380 1996 79 82
45. F. Bunz, P.M. Hwang, C. Torrance Disruption of p53 in human cancer cells alters the responses to therapeutic agents J Clin Invest 104 1999 263 269
46. R.R. Wallace-Brodeur, S.W. Lowe Clinical implications of p53 mutations Cell Mol Life Sci 55 1999 64 75
47. P. Smolewski, J. Grabarek, B.W. Lee Kinetics of HL-60 cell entry to apoptosis during treatment with TNF-α or camptothecin assayed by the stathmo-apoptosis method Cytometry 47 2002 143 149
48. I.F. Tannock, C. Lee Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs Br J Cancer 84 2001 100 105
49. M.T. Sheridan, C.M. West Ability to undergo apoptosis does not correlate with the intrinsic radiosensitivity (SF2) of human cervix tumor cell lines Int J Radiat Biol Phys 50 2001 503 509
50. B. Weber, A.M. Serafin, J. Michie Cytotoxicity and cell death pathways invoked by two new Rhodium ferrocene complexes in benign and malignant prostate cell lines Anticancer Res. 24 2004 763 770
51. J.M. Akudugu Examination of irradiated neuronal cell lines for the interrelationship between micronucleation, repair, apoptosis and cell survival 2000 University of Stellenbosch PhD thesis
52. G.P. Bromfield, A. Meng, P. Warde Cell death in irradiated prostate epithelial cells role of apoptotic and clonogenic cell kill Prostate Cancer and Prostatic Dis 6 2003 73 85
53. P. Beale, P. Rogers, S. Hobbs Transfection of bax into resistant human ovarian carcinoma cell lines confers no sensitisation to chemotherapeutic agents Br J Cancer 78 suppl. 1 1998 30
54. G.G. Steel The case against apoptosis Acta Oncologica 40 2001 968 975